Form 10-Q · Quarterly report
Tesla, Inc. 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0001318605
- Accession no.
- 0001628280-26-049270
Summary
Tesla reported second-quarter 2026 total revenues of $28.24 billion and net income attributable to common stockholders of $1.11 billion, with first-half revenues of $50.62 billion and net income of $1.59 billion. It said it produced approximately 860,000 consumer vehicles, delivered approximately 838,000, and deployed 22.3 GWh of energy storage products through the second quarter, while continuing to expand Robotaxi and prepare Optimus production.
Key points
- Second-quarter 2026 revenues were $28.24 billion and net income attributable to common stockholders was $1.11 billion; first-half revenues were $50.62 billion and net income was $1.59 billion.
- Tesla produced approximately 860,000 consumer vehicles and delivered approximately 838,000 through the second quarter of 2026.
- Tesla deployed 22.3 GWh of energy storage products through the second quarter of 2026.
- Tesla said the current tariff regime would have a relatively larger impact on its energy generation and storage business than on its automotive business.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview We are focused on bringing artificial intelligence into the real world, through products and services like FSD (Supervised) and Robotaxi, as well as working to develop and commercialize AI robots (including Optimus). We intend to leverage our current operations, in which we design, develop, manufacture, sell and lease high-performance fully electric vehicles and energy generation and storage systems that increasingly deliver AI-related and enhanced software and services to our customers, to achieve that objective. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.